In June 2006, a quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil; Merck) was approved by the US FDA for the prevention of several diseases, including cervical cancer, that are caused by these types of human papillomavirus.
Access options
Subscribe to Journal
Get full journal access for 1 year
70,80 €
only 5,90 € per issue
All prices include VAT for France.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
zur Hausen, H. Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2, 342–350 (2002).
- 2.
Lowy, D. R. & Schiller, J. T. Prophylactic human papillo-mavirus vaccines. J. Clin. Invest. 116, 1167–1173 (2006).
- 3.
Kirnbauer, R. et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl Acad. Sci. USA 89, 12180–12184 (1992).
- 4.
Koutsky, L. A. et al. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347, 1645–1651 (2002).
- 5.
Villa, L. L. et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre Phase II efficacy trial. Lancet Oncol. 6, 271–278 (2005).
- 6.
Villa, L. L. et al. Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18. Vaccine 24, 5571–5583 (2006).
- 7.
FDA labelling information [online] (2006).
Author information
Affiliations
Christopher Crum is at the Department of Pathology, Brigham and Women's Hospital, 75 Francis Street Boston, Massachusetts 02115, USA. cpcrum@bics.bwh.harvard.edu
- Christopher Crum
Carole Jones is at IMS Health, 7 Harewood Avenue, London NW1 6JB, UK. cjones@uk.imshealth.com
- Carole Jones
Peter Kirkpatrick is at Nature Reviews Drug Discovery. p.kirkpatrick@nature.com
- Peter Kirkpatrick
Authors
Search for Christopher Crum in:
Search for Carole Jones in:
Search for Peter Kirkpatrick in:
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
About this article
Further reading
-
1.
Biopharmaceutical benchmarks 2010
Nature Biotechnology (2010)
-
2.
Interleukin 21: combination strategies for cancer therapy
Nature Reviews Drug Discovery (2008)
-
3.
Biotrin assay to monitor cervical cancer exposure rates
Nature Biotechnology (2007)